PubMed دسترسی آزاد

Burden of Lip, Oral Cavity, and Pharyngeal Cancers in China: Estimated in 2022 and Projections to 2050.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

INTRODUCTION AND AIMS: Lip, oral cavity, and pharyngeal (LOCP) cancers comprise a heterogeneous group of malignancies with a substantial and evolving disease burden in China. This study aimed to systematically evaluate the burden of LOCP cancers in China and to project future trends. METHODS: Estimates from the GLOBOCAN database were used to quantify the incidence, mortality, and prevalence of LOCP cancers in China in 2022. Future trends were projected through 2050. Subsite-specific analyses were conducted to assess epidemiologic variations and temporal dynamics across different anatomic locations. RESULTS: In 2022, an estimated 116,142 new LOCP cancer cases occurred in China, with a pronounced male predominance. Nasopharyngeal cancer and lip and oral cavity cancer were the major contributors, accounting for 43.9% and 32.0% of cases, respectively, whereas oropharyngeal cancer remained relatively uncommon. Projections indicate a sustained increase in both incidence and mortality across all LOCP cancers through 2050. Notably, lip and oral cavity cancer is expected to show the most pronounced growth, with a potential shift towards becoming a leading contributor, particularly among females. CONCLUSIONS: LOCP cancers impose a substantial and growing burden in China, characterised by marked subsite heterogeneity and evolving epidemiologic trends. These findings highlight the necessity for subsite-specific prevention, early detection, and targeted intervention strategies, as well as the importance of strengthening precision-oriented cancer control frameworks to mitigate future disease burden. CLINICAL RELEVANCE: These findings provide critical evidence to inform national cancer control strategies and advance the paradigm shift towards precision public health and proactive, anticipatory cancer prevention strategies. The observed subsite heterogeneity, coupled with projected increases in lip and oral cavity cancer incidence, underscores the urgent need for more precise, anatomically targeted prevention and early detection frameworks.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

IncidenceMortalityNasopharyngeal cancerOral cavitySalivary gland
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Adverse reactions and safety of nebulized budesonide in elderly patients with inflammatory airway diseases.

BACKGROUND: Budesonide suspension is a first-line inhaled corticosteroid for elderly patients with inflammatory airway diseases, but existing research lacks targeted safety data for the very elderly (≥80 years), systematic analysis of adverse reaction (ADR) temporal distribution and quantitative evidence for modifiable clinical risk factors. OBJECTIVE: To investigate the safety profile, ADR temporal patterns and independent modifiable …

PubMed2026

Biological and Molecular Biomarkers in Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma-Innovation and Insights.

Oral cavity squamous cell carcinoma (OCSCC) represents the 16th most prevalent cancer worldwide accounting for greater than 389,000 cases annually. Most examples of OCSCC are preceded by a diverse group of lesions exhibiting variable risk of transformation to cancer, collectively termed oral potentially malignant disorders (OPMDs). The identification of salivary, serologic, and/or tumor tissue biomarkers holds substantial promise for i…

PubMed2026

Chronic Oral Complications of Oral Cancer Therapy.

Head and neck cancer (HNC) patients are uniquely susceptible to adverse oral health outcomes following head and neck radiation therapy (RT). Various risk factors for these oral health outcomes post-RT were identified in the OraRad study, which followed HNC patients from pre-RT to 2 y post-RT. Chronic oral complications include hyposalivation, trismus, dental caries, periodontal disease, tooth loss, exposed bone, and osteoradionecrosis …

PubMed2026

Diagnostic Adjuncts and Biopsy Techniques for Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma.

Diagnostic adjuncts for oral potentially malignant disorders such as leukoplakia or erythroplakia can aid the clinician in triaging abnormal lesions and facilitate both biopsy site selection and surgical management. No adjuncts replace gold standard biopsy and histopathological examination, and their optimal use requires training and experience. This article covers the potential applications, both in primary and expert settings, of adj…